BIONET Corp. (1784.TWO)

TWD 79.1

(-1.25%)

Net Debt Summary of BIONET Corp.

  • BIONET Corp.'s latest annual net debt in 2023 was -193.47 Million TWD , down -32.19% from previous year.
  • BIONET Corp.'s latest quarterly net debt in 2024 Q2 was -346.59 Million TWD , down -120.87% from previous quarter.
  • BIONET Corp. reported annual net debt of -146.36 Million TWD in 2022, down -36.44% from previous year.
  • BIONET Corp. reported annual net debt of -107.27 Million TWD in 2021, down -5.97% from previous year.
  • BIONET Corp. reported quarterly net debt of -346.59 Million TWD for 2024 Q2, down -120.87% from previous quarter.
  • BIONET Corp. reported quarterly net debt of -193.47 Million TWD for 2023 Q4, down -28.64% from previous quarter.

Annual Net Debt Chart of BIONET Corp. (2023 - 2019)

Historical Annual Net Debt of BIONET Corp. (2023 - 2019)

Year Net Debt Net Debt Growth
2023 -193.47 Million TWD -32.19%
2022 -146.36 Million TWD -36.44%
2021 -107.27 Million TWD -5.97%
2020 -101.23 Million TWD -62.17%
2019 -62.42 Million TWD 0.0%

Peer Net Debt Comparison of BIONET Corp.

Name Net Debt Net Debt Difference
DIVA Laboratories, Ltd. -534.39 Million TWD 63.795%
Genetics Generation Advancement Corp. -79.18 Million TWD -144.343%
Welgene Biotech Co.,Ltd. -33.78 Million TWD -472.708%
Puriblood Medical Co., Ltd. -65.84 Million TWD -193.856%
TFBS Bioscience Inc. -797.57 Million TWD 75.742%